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Introduction: The aim of this study was to describe associations
between lung tumor location and smoking as well as selected
occupational exposures. In the context of lung cancer screening by
computed tomography scan, tumor location may have an interest.
Computed tomography scan is known to better detect more periph-
eral tumors.
Methods: Lung cancer cases diagnosed in two French University
hospitals between 1997 and 2009 were included. Tumors visible on
white-light bronchoscopy were defined as central. Occupational
exposures were assessed by the same expert. Data were analyzed by
case-case comparisons using unconditional logistic regressions.
Results: A total of 1701 cases were included, comprising mainly
men (86.3%), current smokers (52.8%), or former smokers (42.8%).
Main histological subtypes of cancer were adenocarcinomas
(33.8%) and squamous cell carcinomas (32.6%). The tumor location
was found to be central in 61% of cases, and never smokers and
women had more often peripheral tumors. Exposure to asbestos was
significantly associated with central location with dose-response
relationship (odds ratio [OR] for peripheral tumors  0.45, 95%
confidence interval [CI] 0.29–0.70) for the highest level of expo-
sure. Exposure to silica dust was significantly associated with
peripheral tumor (OR for peripheral tumors  3.28, 95%CI 1.50–
7.17) for the highest level of exposure. Exposure to welding fumes
was associated with central location (OR for peripheral tumors 
0.51, 95% CI 0.26–0.96) for the first level of exposure).
Conclusions: Smoking characteristics and occupational exposures
have to be considered to define more accurately high-risk popula-
tions suitable for lung cancer screening or early detection programs.
Key Words: Asbestos, Lung cancer screening, Bronchial neoplasm,
Occupational exposure, Silica, Tobacco smoking.
(J Thorac Oncol. 2012;7: 128–136)
Lung cancer has been the most common cancer in the worldfor several decades among of all new cancers. It was also
the leading cause of death from cancer, with 1.4 million
deaths. The overall 5-year survival rate is only 15% despite
many advances in imaging techniques and oncological care
over the past few decades.1,2 Thus, an efficient mass screen-
ing of lung cancer, particularly, by low-dose computed to-
mography (CT) scan3–5 would be of importance to enhance
the very poor prognostic of this disease. In this context, tumor
locations (central or peripheral) may have a significant influ-
ence regarding screening, high-risk population surveillance,
or early diagnosis strategies. In particular, CT scan is known
to better detect more peripheral tumors because of the pres-
ence of numerous structures in the hilar areas like vessels or
adenopathy.6–8 Conversely, bronchoscopy (autofluorescence
bronchoscopy) is the main tool for the diagnosis of centrally
located tumors. Autofluorescence bronchoscopy has a high
sensitivity in detecting precancerous bronchial lesions but can
only visualize tumors in first bronchial divisions.9–13 As a
result, some authors proposed to associate the two methods in
very high-risk subjects.14 Other multimodality strategies, also
including novel biological tools, are still under review.12,15,16
Histological subtypes are one of the main factors influ-
encing location of tumor in the lungs. Squamous or small cell
carcinomas tend to be central tumors, whereas adenocarcino-
mas (ADCs) and large cell carcinomas (LCCs) are most often
peripheral. There are also some associations described be-
tween histology or location (central versus peripheral) of lung
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cancer and some risk factors such as smoking or occupational
lung carcinogens inhalation, but these studies are controver-
sial and often ancient.6,10,17–26
The main objective of our study was to investigate the
associations between a series of occupational risk factors and
lung cancer location in a group of 1701 patients in whom
detailed occupational and smoking histories were collected.
PATIENTS AND METHODS
Patients
This study included all incident cases of lung cancer
diagnosed in the Respiratory Diseases Department of Rouen
University Hospital from January 1, 1997 through December
31, 2005 and subsequently in the Thoracic Surgery and
Respiratory Diseases Departments of Nancy University Hos-
pital from January 1, 2001 through June 31, 2009. Details
have been previously published.23,27
Tumor Location
All patients underwent white-light bronchoscopy using
a 4.5-mm endoscope. Tumors accessible and visible on this
examination were defined as central. The remaining tumors
were defined as peripheral.
Histological Diagnosis
We used all available pathologic samples. Within each
University Hospital, samples were analyzed by a single
pathologist with extensive experience in the pathologic diag-
nosis of lung cancer. Histological types were classified ac-
cording to the International Classification of Lung Tumors28
by the following five categories: squamous cell carcinoma
(SCC), ADC, small cell carcinoma (SCLC), undifferentiated
LCC, and other cancer types.
Smoking Data
Data were collected in a face-to-face interview, based
on a standardized questionnaire. All subjects were systemat-
ically interviewed about their current and lifetime smoking
status. Detailed data were obtained about the tobacco con-
sumption history including: smoking, age of starting, current
smoking status, duration, intensity (number of cigarettes per
day), and age at cessation when relevant. Patients who quitted
smoking more than 1 year ago were considered as former
smokers. Patients who had smoked less than 100 cigarettes in
their lifetime were defined as never smokers.
Occupational Exposures Assessment
The occupational questionnaire was focused on the
main lung cancer carcinogens (asbestos, chromium, arsenic,
cadmium, silica, nickel, welding fumes, diesel exhausts,
polycyclic aromatic hydrocarbons (PAHs), and ionizing ra-
diation exposure by radon) and was based on a description of
all jobs (held for at least 6 months) and on systematic
questions about specific exposing tasks. Cumulative exposure
scores were computed for each factor as the product of the
intensity, the probability, the frequency, and the duration of
the exposure, summed over all work periods of the person’s
occupational history. Occupational exposures to lung carcin-
ogens were assessed by an occupational physician according
to a previously described method.27
Statistical Analysis
The statistical analysis was aimed at identifying the
different factors associated with peripheral versus central
bronchial tumor location and is thus based on case–case
comparisons. Tumor location was first cross-tabulated with
gender, age, histological types, smoking variables, and doc-
umented exposure to the occupational lung carcinogens de-
fined as exposure duration of at least 1 year with a frequency
greater than or equal to 5% of the yearly work-time.
Associations between location and categorical vari-
ables were assessed using Pearson’s chi-square test or, when
appropriate, Fisher’s exact test, depending on the sample size.
Cochran’s test was used to assess trends with asymptotic or
exact p values depending on sample size. Associations be-
tween location and continuous variables were assessed using
Student t test.
Multiple unconditional logistic regressions with back-
ward stepwise selection variables independently associated
with tumor location (peripheral versus central). All the vari-
ables with a p value less than or equal to 10% in the
single-factor analyses were included in the logistic regression
model. Age and sex were forced, if necessary, into the models
to obtain age and sex-adjusted estimates of odds ratios (ORs).
Interactions were assessed between the different occupational
exposures and between occupational exposures and the smok-
ing variables, smoking status (current smokers, former smok-
ers, and never smokers), duration since smoking cessation,
and cumulative tobacco consumption (pack-years). A p value
less than 5% was deemed statistically significant. Because
this study is restricted to subjects with lung cancer, the OR
does not represent an estimate of the effect of occupational
exposure on the occurrence of disease but should be inter-
preted as the effect of exposure on the distribution of tumor
locations. All analyses were performed using SAS (SAS
Institute Inc., Cary, NC, release 9.0) or SPSS (SPSS Inc.,
Chicago, IL, Statistics 17.0) software.
RESULTS
Overall, 1701 subjects were included in this study
(Table 1). The sample included mainly men (n  1468,
86.3%) with a sex ratio of 6.3. Only 75 subjects were never
smokers (4.4%). The main histological types of lung cancer
observed were ADC (n  33, 8%), SCC (32.6%), SCLC
(16.1%), and LCC (9.5%). The tumor location was central in
61% of the tumors.
Documented occupational exposures to at least one
lung carcinogen whatever intensity were identified in 1076
subjects (63.3%), mainly men. Asbestos exposure was
detected in 571 patients (33.6%), PAHs exposure in 168
patients (9.9%), welding fumes exposure in 167 (9.8%),
diesel exhausts exposure in 165 (9.7%), silica exposure in
105 (6.2%), chromium exposure in 16 (0.9%), ionizing
radiation exposure in 11 (0.6%), and other exposures in 73
subjects (4.3%).
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Factors Associated With Central Versus
Peripheral Tumor Location
Histological type of tumor was strongly associated with
tumor location (p 103) (Table 2). ADC tumors were more
often located in the periphery of the lungs (53.9%, crude
OR  4, 95% confidence interval [CI] 2.88–5.54 with SCLC
as reference; Table 3). Female gender was also associated
with a peripheral tumor location (crude OR  1.56, 95% CI
1.18–2.06). Smoking was associated with tumor location;
compared with current smokers, the tumor location of never
smokers was significantly more often peripheral (OR 1.74,
95% CI 1.08–2.79). Duration of smoking and cumulative
consumption were also significantly associated with tumor
location (exact trend test, p  0.001 and p  0.027 respec-
tively); the higher the smoking indices were, the more the
patients had central tumors. We also observed an inverse
relationship with duration since cessation (exact trend test,
p  0.023). With respect to occupational carcinogens (Table
3), exposure to asbestos showed the strongest correlation with
central tumor location (65% vs 58.9% in non-exposed, p 
0.016) with a significant dose-response relationship with
cumulative exposure index to asbestos (p  0.001, exact
trend test). Occupational exposure to welding fumes showed
also a close to significant association with more central
tumors location (p  0.089), albeit no clear trend was
observed with cumulative exposure indice. Occupational ex-
posure to silica was by contrast related with peripheral
locations only for the higher quartile of cumulative exposure
indice relative to non exposed subjects (OR  2.59 (95% CI:
1.21–5.53). Other lung carcinogens did not show any signif-
icant relation with tumor location.
After adjusting for age, gender, and smoking status
using logistic regression models (Table 4), exposure to silica,
welding fumes, and asbestos remained still independently
significant. Asbestos was strongly associated with a central
tumor location, the dose-response relationships with cumula-
tive exposure indice being still significant (exact trend test,
p  0.002). Welding fumes exposure also remained associ-
ated with central locations after adjustment, albeit no signif-
icant trend was again observed with cumulative exposure
index categories. By contrast, adjusted ORs for the different
levels of silica exposure showed a more coherent association
with peripheral location, with a significant dose-effect rela-
tionship with cumulative exposure to silica (adjusted OR
3.28, 95% CI 1.50–7.17) for the highest level of silica
exposure (exact trend test, p  0.011). Multivariate analysis
with inclusion of cancer histological types into the model did
not modify results except for smoking status that became
nonsignificant (Table 5). The different interactions between
each of the occupational exposures and between smoking
status and occupational exposures were not significant (data
not shown).
DISCUSSION
Our results highlight the existence of preferential bron-
chial location of lung cancer for several occupational expo-
sures, namely asbestos, silica, and welding fumes. Moreover,
these associations are supported by significant dose-response
TABLE 1. Characteristics of the Study Patients According to
Gender and Overall
Total
(N  1701)
Males
(N  1468,
86.3%)
Females
(N  233,
12.7%)
Age (yr)
Mean (SD) 62.01 (10.36) 62.48 (10.2) 59.00 (10.9)
0–54 464 (27.3) 372 (25.3) 92 (39.5)
55–69 773 (45.4) 679 (46.3) 94 (40.3)
69 464 (27.3) 417 (28.4) 47 (20.2)
Histologic types
SCLC 274 (16.1) 230 (15.7) 44 (18.9)
ADC 575 (33.8) 473 (32.2) 102 (43.9)
SCC 571 (33.6) 520 (35.4) 51 (21.9)
LCC 162 (9.5) 142 (9.7) 20 (8.6)
Others 119 (7.0) 103 (7.0) 16 (6.9)
Lung tumor localization
Central 1037 (61.0) 917 (62.5) 120 (51.5)
Peripheral 664 (39.0) 551 (37.5) 83 (48.5)
Lung lobes localization
Other 626 (36.8) 543 (37.0) 83 (35.6)
Upper lobes 1075 (63.2) 925 (63.0) 150 (64.4)
Tobacco status
Never smokers 75 (4.4) 38 (2.6) 37 (15.9)
Long-term (10 yr)
former smokers
408 (24.0) 382 (26.0) 26 (6.4)
Short-term (10 yr)
former smokers
320 (18.8) 285 (19.4) 35 (15.0)
Current smokers 898 (52.8) 763 (52.0) 135 (57.9)
Pack-years
Median 42.00 42.00 40.5
Mean (SD) 45.59 (23.9) 46.06 (24.1) 42.15 (22.3)
Cigarettes/day
Median 20.00 20.00 20.00
Mean (SD) 24.29 (11.0) 24.24 (11.0) 24.64 (10.6)
Smoking duration (yr)
Median 38.00 39.00 34.00
Mean (SD) 37.88 (11.0) 38.36 (10.9) 34.37 (11.2)
Time since quitting
smoking (yr)
Median 11.00 11.00 7.00
Mean (SD) 13.44 (10.4) 13.62 (10.4) 11.38 (10.8)
Occupational exposures
Asbestos 571 (33.6) 561 (38.2) 10 (4.3)
Polycyclic aromatic
hydrocarbons
168 (9.9) 168 (11.4) 0
Silica 105 (6.2) 103 (7.0) 2 (0.9)
Welding fumes 167 (9.8) 165 (11.2) 2 (0.9)
Diesel exhaust 165 (9.7) 165 (11.2) 0
Chrome 16 (0.9) 16 (1.1) 0
Radioisotopes and
ionizing radiations
11 (0.6) 10 (0.7) 1 (0.4)
Other carcinogen
exposures
73 (4.3) 66 (4.5) 7 (3.0)
Data are presented as N (%).
SD, standard deviation; SCC, squamous cell carcinoma; ADC, adenocarcinoma;
SCLC, small cell carcinoma; LCC, undifferentiated large cell carcinoma.
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relationships. Our results also strongly support previous
reports linking tobacco smoke exposure to a preferential
central localization of lung cancer in bronchial airways.1,29
Therefore, our study confirmed that that bronchial location
is associated with risk factors of lung cancer. Finally,
tumor location has often been associated with histological
types of cancer, and ours results confirm, if needed, this
strong correlation.1,20,29,30
Non-small cell carcinomas represent more than 83% of
our cases, which is consistent with previous reports about
TABLE 2. Lung Tumor Location (Peripheral vs. Central) According to Demographic, Pathologic
Characteristics, and Smoking Status in 1701 Lung Cancer Patients (Unadjusted Analysis)
Central
(N  1037, 61.0%)
Peripheral
(N  664, 39.0%) p OR (95% CI)
Gender
Males 917 (62.5) 551 (37.5) 0.001a 1.00
Females 120 (51.5) 113 (48.4) 1.56 (1.18–2.06)
Age (yr)
Mean (SD) 62.27 (10.3) 61.59 (10.3) 0.182b
0–54 274 (59.1) 190 (40.9) 0.552a 1.00
55–69 473 (61.2) 300 (38.8) 0.91 (0.72–1.15)
69 290 (62.5) 174 (37.5) 0.86 (0.66–1.12)
Tobacco status
Never smokers 37 (49.5) 38 (50.7) 0.074a 1.74 (1.08–2.79)
Long-term (10 yr) former smokers 238 (58.3) 170 (41.7) 0.017c 1.21 (0.95–1.53)
Short-term (10 yr) former smokers 197 (61.6) 123 (38.4) 1.05 (0.81–1.37)
Current smokers 565 (62.9) 333 (37.1) 1.00
Tobacco consumption (pack-years)
0 (nonsmokers) 38 (50.0) 38 (50.0) 0.191a 1.76 (1.07–2.89)
1–19 96 (59.6) 65 (40.4) 0.027c 1.19 (0.81–1.74)
20–39 311 (59.5) 212 (40.5) 1.20 (0.91–1.57)
40–59 348 (62.3) 211 (37.7) 1.06 (0.81–1.39)
60 243 (63.8) 138 (36.2) 1.00
Smoking duration (yr)
0 (nonsmokers) 38 (50.0) 38 (50.0) 0.003a 2.42 (1.44–4.09)
1–19 42 (57.5) 31 (42.5) 0.001c 1.79 (1.07–2.89)
20–29 139 (57.7) 102 (42.5) 1.78 (1.23–2.57)
30–39 323 (58.5) 229 (41.5) 1.72 (1.25–2.35)
40–49 306 (62.2) 186 (37.8) 1.47 (1.07–2.03)
50 187 (70.8) 77 (29.2) 1.00
Time since quitting smoking (yr)
0–1 (current smokers) 565 (62.9) 333 (37.1) 0.373a 1.00
1–4 98 (63.2) 57 (36.8) 0.023c 0.98 (0.69–1.40)
5–9 99 (60.0) 66 (40.0) 1.13 (0.80–1.58)
10–14 69 (58.5) 49 (41.5) 1.20 (0.81–1.78)
15–19 65 (57.5) 48 (42.5) 1.25 (0.84–1.86)
20 141 (56.0) 111 (44.0) 1.33 (1.00–1.77)
Histological types
SCLC 212 (77.4) 62 (22.6) 0.001a 1.00
ADC 265 (46.1) 310 (53.9) 4.00 (2.88–5.54)
SCC 409 (71.6) 162 (28.4) 1.35 (0.96–1.89)
LCC 87 (53.7) 75 (46.3) 2.94 (1.93–4.48)
Others 64 (53.8) 55 (46.2) 2.93 (1.85–4.64)
Lung lobes localization
Other 398 (63.6) 228 (36.4) 0.092a 1.00
Upper lobes 639 (59.4) 436 (40.6) 1.19 (0.97–1.46)
Data are presented as N (%).
a Overall Pearson chi-square test or Fisher’s exact test.
b Student’s t test.
c Overall chi-square test for trend test.
SCC, squamous cell carcinoma; ADC, adenocarcinoma; SCLC, small cell carcinoma; LCC, undifferentiated large cell carcinoma; SD,
standard deviation; OR, odds ratio; CI, confidence interval.
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TABLE 3. Lung Tumor Location (Peripheral vs. Central) According to Occupational Exposures in
1701 Lung Cancer Patients (Unadjusted Analysis)
Total
(N  1701)
Central
(N  1037, 61.0)
Peripheral
(N  664, 39.0) p OR (95% CI)
Asbestos—cumulative exposure index
(fiber/ml yr)
0-not exposed 1130 (66.4) 666 (58.9) 464 (41.1) 0.001a 1.00
Low 241 (14.2) 146 (60.6) 95 (39.4) 0.001b 0.93 (0.70–1.24)
Moderate 195 (11.5) 122 (62.6) 73 (37.4) 0.85 (0.62–1.17)
High 135 (7.9) 103 (76.3) 32 (23.7) 0.44 (0.29–0.67)
Asbestos
Not exposed 1130 (66.4) 666 (58.9) 464 (41.1) 0.016a 1.00
Exposed 571 (33.6) 371 (65.0) 200 (35.0) 0.77 (0.62–0.95)
Polycyclic aromatic hydrocarbons—
cumulative exposure index
0-not exposed 1533 (90.1) 941 (61.4) 592 (38.6) 0.425a 1.00
Low 58 (3.4) 30 (51.7) 28 (48.3) 0.621b 1.48 (0.87–2.50)
Moderate 73 (4.3) 42 (57.5) 31 (42.5) 1.17 (0.72–188)
High 37 (2.2) 24 (64.9) 13 (35.1) 0.86 (0.43–1.70)
Polycyclic aromatic hydrocarbons
Not exposed 1533 (90.1) 941 (61.4) 592 (38.6) 0.285a 1.00
Exposed 168 (9.9) 96 (57.1) 72 (42.9) 1.19 (0.86–1.64)
Silica—cumulative exposure index
0-not exposed 1596 (93.8) 979 (61.3) 617 (38.7) 0.083a 1.00
Low 43 (2.5) 26 (60.5) 17 (39.5) 0.062b 1.03 (0.55–1.92)
Moderate 33 (1.9) 21 (63.6) 12 (36.4) 0.90 (0.44–1.85)
High 29 (1.7) 11 (37.9) 18 (62.1) 2.59 (1.21–5.53)
Silica
Not exposed 1596 (93.8) 979 (61.3) 617 (38.7) 0.214a 1.00
Exposed 105 (6.2) 58 (55.2) 47 (44.8) 1.28 (0.86–1.91)
Welding fumes—cumulative exposure
index
0-not exposed 1534 (90.2) 925 (60.3) 609 (39.7) 0.011a 1.00
Low 60 (3.5) 47 (78.3) 13 (21.7) 0.264b 0.42 (0.22–0.78)
Moderate 52 (3.1) 27 (51.9) 25 (48.1) 1.40 (0.80–2.44)
High 55 (3.2) 38 (69.1) 17 (30.9) 0.68 (0.38–1.21)
Welding fumes
Not exposed 1534 (90.2) 925 (60.3) 609 (39.7) 0.089a 1.00
Exposed 167 (9.8) 112 (67.1) 55 (32.9) 0.74 (0.53–1.04)
Diesel exhaust
Not exposed 1536 (90.3) 929 (60.5) 607 (39.7) 0.213a 1.00
Exposed 165 (9.7) 108 (65.5) 57 (34.5) 0.80 (0.57–1.13)
Chrome
Not exposed 1685 (99.1) 1028 (61.0) 657 (38.9) 0.698a 1.00
Exposed 16 (0.9) 9 (56.3) 7 (43.8) 1.21 (0.45–3.28)
Radioisotopes and ionizing radiations
Not exposed 1690 (99.4) 1032 (61.1) 658 (38.9) 0.290a 1.00
Exposed 11 (0.6) 5 (45.5) 6 (54.5) 1.88 (0.57–6.19)
Other carcinogen exposures
Not exposed 1628 (95.7) 993 (61.0) 635 (39.0) 0.902a 1.00
Exposed 73 (4.3) 44 (60.3) 29 (39.7) 1.03 (0.63–1.66)
Data are presented as N (%).
a Overall Pearson chi-square test or Fisher’s exact test.
b Overall chi-square test for trend test.
OR, odds ratio; CI, confidence interval.
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lung cancer histological type distribution in Western coun-
tries.1 SCC and SCLC occur mainly in the large central
bronchi, compared with ADC or LCC, more located in the
peripheral sections of the lung. Overall, we found a quite high
proportion of central tumor location, both in males and
females. According to our results, this may be explained by
the high rate of occupational carcinogen exposures in males
and, conversely, the low percentage of nonsmokers in fe-
males. We found very coherent associations, including dose-
response relationships, between bronchial location of lung
cancer and smoking, considering duration of consumption
and pack-years smocked (associated with a central location)
and, conversely, for duration since cessation or no smoking
(associated with peripheral location). Interestingly, these re-
lations were no more significant after adjustment on histo-
logical types, demonstrating the strong correlation between
TABLE 4. Adjusted (Not Including Histology) ORs
Associated with Lung Peripheral Tumor Location vs. Central
Tumor Location in 1701 Lung Cancer Patients (Unconditional
Logistic Regression)
Peripheral Tumor
Location vs.
Central, N (%)
Adjusted OR for
Peripheral Tumor
Location (95% CI) p
Gender
Males 551 (37.5) 1.00
Females 113 (48.4) 1.41 (1.04–1.90) 0.023
Age (yr)
0–54 190 (40.9) 1.00 0.199
55–69 300 (38.8) 0.88 (0.68–1.12)
69 174 (37.5) 0.76 (0.56–1.02)
Tobacco status
Never smokers 38 (50.7) 1.69 (1.03–2.77) 0.044
Long-term (10 yr)
former smokers
170 (41.7) 1.36 (1.04–1.78) 0.004a
Short-term (10 yr)
former smokers
123 (38.4) 1.16 (0.89–1.53)
Current smokers 333 (37.1) 1.00
Asbestos—cumulative
exposure index
(fiber/ml yr)
0-not exposed 464 (41.1) 1.00 0.005
Low 95 (39.4) 1.01 (0.75–1.35) 0.002a
Moderate 73 (37.4) 0.91 (0.66–1.26)
High 32 (23.7) 0.45 (0.29–0.70)
Welding fumes—
cumulative
exposure index
0-not exposed 609 (39.7) 1.00 0.042
Low 13 (21.7) 0.51 (0.26–0.96) 0.868a
Moderate 25 (48.1) 1.66 (0.94–2.93)
High 17 (30.9) 0.80 (0.44–1.46)
Silica—cumulative
exposure index
0-not exposed 617 (38.7) 1.00 0.029
Low 17 (39.5) 1.13 (0.60–2.14) 0.011a
Moderate 12 (36.4) 1.09 (0.52–2.27)
High 18 (62.1) 3.28 (1.50–7.17)
Variables included in the model are gender, age, smoking status, exposure to silica,
exposure to asbestos, and exposure to welding fumes (age was forced into the model).
Hosmer-Lemershow’s overall goodness of fit statistics  3.28, df  8, p  0.915.
a p value for trend test.
OR, odds ratio; CI, confidence interval.
TABLE 5. Adjusted (Including Histology) ORs Associated
with Lung Peripheral Tumor Location vs. Central Tumor
Location in 1701 Lung Cancer Patients (Unconditional
Logistic Regression)
Peripheral Tumor
Location vs.
Central, N (%)
Adjusted OR for
Peripheral Tumor
Location (95% CI) p
Gender
Males 551 (37.5) 1.00 0.045
Females 113 (48.4) 1.37 (1.00–1.87)
Age (yr)
0–54 190 (40.9) 1.07 (0.78–1.45) 0.879
55–69 300 (38.8) 1.06 (0.56–1.02)
69 174 (37.5) 1.00
Tobacco status
Never smokers 38 (50.7) 1.22 (0.73–2.05) 0.406
Long-term (10 yr)
former smokers
170 (41.7) 1.23 (0.93–1.62) 0.101a
Short-term (10 yr)
former smokers
123 (38.4) 1.17 (0.88–1.55)
Current smokers 333 (37.1) 1.00
Asbestos—cumulative
exposure index
(fiber/ml yr)
0-not exposed 464 (41.1) 1.00 0.016
Low 95 (39.4) 1.03 (0.76–1.40) 0.004a
Moderate 73 (37.4) 0.89 (0.63–1.25)
High 32 (23.7) 0.48 (0.31–0.76)
Welding fumes—
cumulative
exposure index
0-not exposed 609 (39.7) 1.00 0.035
Low 13 (21.7) 0.46 (0.23–0.89) 0.510a
Moderate 25 (48.1) 1.52 (0.84–2.75)
High 17 (30.9) 0.71 (0.38–1.32)
Silica—cumulative
exposure index
0-not exposed 617 (38.7) 1.00 0.044
Low 17 (39.5) 1.17 (0.60–2.26) 0.014a
Moderate 12 (36.4) 1.08 (0.50–2.31)
High 18 (62.1) 3.13 (1.41–6.95)
Histologic types
SCLC 274 (16.1) 1.00 103
ADC 575 (33.8) 3.92 (2.80–5.47)
SCC 571 (33.6) 1.36 (0.97–1.92)
LCC 162 (9.5) 2.85 (1.86–4.36)
Others 119 (7.0) 3.01 (1.88–4.83)
Variables included in the model are gender, age, smoking status, histological types,
exposure to silica, exposure to asbestos, and exposure to welding fumes (age was forced
into the model). Hosmer-Lemershow’s overall goodness of fit statistics  7.49, df  8,
p  0.485.
a p value for trend test.
SCC, squamous cell carcinoma; ADC, adenocarcinoma; SCLC, small cell carci-
noma; LCC, undifferentiated large cell carcinoma; OR, odds ratio; CI, confidence
interval.
Journal of Thoracic Oncology • Volume 7, Number 1, January 2012 Lung Cancer Location and CT Scan Screening
Copyright © 2011 by the International Association for the Study of Lung Cancer 133
heavy smoking, SCC, and central localization of lung cancer.
As a result, the changes in epidemiology of lung cancer
histology, with a well-known shift between SCC and ADC
frequency over past decades,1,25,31,32 are likely to have also
modified anatomic distribution of lung cancer (peripheral
airway versus central airway). However, to our knowledge,
this point has not yet been documented.
Literature about occupational asbestos exposure and bron-
chial location of lung cancer remains unclear.10,17–23,25–27,30
Johansson et al.30 in a case series of asbestos cement workers
found a tendency for peripheral localization in relation to the
more frequent association with ADC, but the correlation was
not significant and only based on unadjusted analyses. Ak et
al.26 in a study on 795 lung cancer cases report a significant
association between asbestos exposure and peripheral local-
ization of tumor in 88 subjects with asbestos-related radio-
logical findings. However, the study concerned a selected
group, the definition of asbestos exposure was imprecise
including environmental exposure, and the results were based
only on unadjusted analyses. Paris et al.23 in a first report
published in 2003 including a much smaller group of cases
(n 217) found a border-line significant association between
asbestos exposure with peripheral tumor location. In addition,
a significant association was found with smoking status,
suggesting an interaction between occupational asbestos ex-
posure and smoking quitting status especially in long-term
ex-smokers. Our present study, including those of this earlier
study, did not confirm these results and, by contrast, showed
a significant association of asbestos exposure with a central
tumor location confirmed by a clear dose-response relation-
ship with cumulative exposure.
Our study also found significant correlations between
welding fumes exposure and central airways locations and
between silica exposure and peripheral tumors. To the best of
our knowledge, it is the first study that reported such associ-
ations. Some authors have described relations between histo-
logical types of lung tumor among workers exposed that
could be considered indirectly as an indicator of bronchial
location. Thus, in a recent publication, Siew et al.33 found an
association between exposure to welding fumes and risk of
lung cancer mainly of SCC, known to be located mainly in
central airways, among a cohort of active Finnish men fol-
lowed up from 1971 to 1995 with a relative risk of 1.55 (95%
CI 1.08–2.24); conversely, Paris et al.27 found a significant
association between welding fumes exposure and the ADC
frequency among the same cases as ours. A recent meta-
analysis showed a 26% excess of lung cancer for welders
without any difference according to welding activities.34
Concerning silica, in a large multicenter case-control study
conducted in seven European countries showing a significant
risk of lung cancer, Cassidy et al.35 did not retrieve any
specific association with a particular histological type.
In summary, we found a clear relationship between
central localization of lung cancer and heavy smoking that
could be explained by histology. Conversely, preferential
association between localization and occupational exposures
(asbestos, silica, and welding fumes) remained significant
even after histology adjustment. Explanations of these find-
ings were difficult. One can first hypothesize that these
discrepancies may be linked to preferential deposition of
particles. The factors influencing the deposit of asbestos
fibers by sedimentation or impaction in the airways and
bifurcations of the bronchial tree36,37 as well as interactions
with smoking38 may have a role in tumor location and
possibly could explain discrepancies according to different
studies. Under this hypothesis, central location of lung cancer
in asbestos-exposed subjects would be due to the interaction
with tobacco smoking. Nevertheless, we did not find any
statistical interaction between smoking categories and asbes-
tos exposure on bronchial location of lung cancer, so that no
clear explanation could be given. Moreover, Churg19 have
demonstrated the absence of correlation between concentra-
tion of amosite fibers in the lungs and preferential distribution
of asbestosis. Aggregates of different particles can also mod-
ify size, transport patterns, and deposition in lung airways.
Welding fumes as silica dust (but also tobacco fume) can
contain ultrafine particles with specific effects on lung
cells.39–42 The effects are stronger for fine and ultrafine
particles because they can penetrate deeper into the airways
of the respiratory tract and can reach the alveoli in which 50%
are retained in the lung parenchyma. The evaluation of most
of studies shows that the smaller the size of particulate
matter, the higher the toxicity is through mechanisms of
oxidative stress and inflammation.40–42 However, no correla-
tions can be shown between fine and ultrafine particles and a
preferential central or peripheral carcinogen action in the
literature data. Accordingly, and as suggested by our findings,
we assume the hypothesis that variation of bronchial location
of lung cancer in relation with risk factors is probably more
in relation with carcinogens properties, and genetic mecha-
nisms than mechanical factors (e.g., deposition distribution).
For instance, associations between asbestos fiber length and
lung cancer,43,44 as well as PAHs and SCC,45,46 supported this
explanation.
Some limitations of our study needed to be discussed.
First, our population was recruited in only two hospitals.
Moreover, these two hospitals are based in two areas with
former heavy industries that lead to high percentages of
occupational exposures. Most of patients were symptoms
diagnosed and not screened detected; the number of patients
included after an individual screening by chest X-ray or CT
scan is not known, and this could slightly modify initial
bronchial location proportion. As a result, our subjects cannot
be considered as representative of all cases; however, com-
parisons with literature data suggest that our cases are
roughly comparable with French lung cancer patients. Fi-
nally, even if these elements can influence the distribution of
bronchial tumor location, we can assume that, thanks to the
case–case comparison, these points do not influence our
findings to any extent. Beyond these limitations, the main
strengths of our study are the large number of incident cases
selected, the detailed occupational exposure assessment, and
the fact that few studies on this topic are available in the
recent literature. Case–case comparisons permitted also to
avoid some bias selection among comparisons because se-
lected subjects are totally independent of phenotypes of lung
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cancer studied here. In addition, the comparisons of reports
concerning the tumor distribution of lung cancers are difficult
because of methodological differences in definition of cen-
tral/peripheral location according to the authors.
Our results indicate that characteristics of smoking and
some occupational exposures are clearly associated with
bronchial location of lung cancer. Evolution of smoking
habits and occupational exposure prevention may result in a
sizable modification of the distribution of bronchial location
of lung cancer. Regarding the poor performance of low-dose
CT scan to detect hilar nodules,5,6,47 this may affect efficiency
of lung cancer screening, in particular in long-term former
smokers or, in a lesser extent, as suggested by our study, in
patients being exposed to silica. To our knowledge, to date,
no study specifically addresses this issue regarding the sur-
vival of lung cancer patients according to their occupational
risk factors. The recent findings of the National Lung Screen-
ing Trial, the largest randomized controlled trial under way,
report a significant reduction (20.0%; 95% CI 6.8–26.7) of
lung cancer mortality among older current or former smokers
screened with a low-dose helical CT.48 It would be of great
interest to analyze these findings accordingly to the risk
factors and location of detected lung cancer. Indeed, if we do
not think that our results may invalidate the efficacy of lung
cancer CT scan screening suggested by this recent trial, our
findings suggest that this benefit may be less high in some
specific populations, namely heavy smokers or occupation-
ally exposed to asbestos subjects. In addition, specific
strategies of screening have to be designed. Finally, our
results suggest that smoking characteristics and occupa-
tional exposures have an effect on the development of a
central or peripheral location of lung cancer. This effect
may need to be considered in defining high-risk popula-
tions suitable for lung cancer screening by CT scan or
other early detection programs.
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